Navigation Links
OncoSec Medical to Present at the 15th Annual BIO CEO & Investor Conference
Date:2/6/2013

able to minimize detrimental effects resulting from currently available cancer treatments such as surgery, systemic chemotherapy or immunotherapy and other treatment alternatives.  OncoSec Medical's core technology is based upon its proprietary use of an electroporation platform to dramatically enhance the delivery and uptake of a locally delivered DNA-based immunocytokine (ImmunoPulse) or chemotherapeutic agent (NeoPulse). Treatment of various solid cancers using these powerful and targeted anti-cancer agents has demonstrated selective destruction of cancerous cells while sparing healthy normal tissues during early and late stage clinical trials. OncoSec's clinical programs include three Phase II clinical trials for ImmunoPulse targeting lethal skin cancers. More information is available at http://www.oncosec.com/.

This press release contains forward looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Any statements in this release that are not historical facts may be considered such "forward looking statements." Forward looking statements are based on management's current preliminary expectations and are subject to risks and uncertainties which may cause our results to differ materially and adversely from the statements contained herein. Some of the potential risks and uncertainties that could cause actual results to differ from those predicted include our ability to raise additional funding, our ability to acquire, develop or commercialize new products, uncertainties inherent in pre-clinical studies and clinical trials, unexpected new data, safety and technical issues, competition and market conditions. These and additional risks and uncertainties are more fully described in OncoSec Medical's filings with the Securities and Exchange Commission. Undue reliance should not be placed on forward look
'/>"/>

SOURCE OncoSec Medical Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. OncoSec Medical to Present at Noble Financial Capital Markets Ninth Annual Equity Conference on January 22
2. OncoSec Medical Announces $7.2 Million Public Offering
3. OncoSec Medical to Present Data at DNA Vaccines 2012 Conference
4. OncoSec Medical Reports Positive Preliminary Efficacy Results from Phase II Study of ImmunoPulse in Metastatic Melanoma Patients
5. OncoSec Medical Reports Positive Interim Efficacy Results from Phase IV Study of NeoPulse in Skin Cancer Patients
6. OncoSec to Present at Upcoming Healthcare and Investor Conferences
7. OncoSec Granted New Patent from China
8. OncoSec to Present at the Rodman & Renshaw 2012 Annual Global Investment Conference
9. OncoSec Featured on KTVU-TV News and in San Francisco Chronicle
10. OncoSec OMS ElectroChemotherapy for Head and Neck Cancer Shows Enhanced Quality of Life in Two Randomized Phase III Studies
11. OncoSec Establishes Clinical Site for Its Phase II Merkel Cell Carcinoma Trial at University of California San Francisco (UCSF)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... 28, 2015 Amgen (NASDAQ: AMGN ) ... $0.79 per share dividend for the third quarter of ... 2015, to all stockholders of record as of the ... About Amgen Amgen is committed to unlocking the ... by discovering, developing, manufacturing and delivering innovative human therapeutics. ...
(Date:7/28/2015)... 2015 Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX ... 2015 financial results after the market closes on Tuesday, ... webcast will be held on Tuesday, August 4, 2015, ... To participate in the call, please dial ... A rebroadcast of the teleconference will be available for ...
(Date:7/28/2015)... Research and Markets ( http://www.researchandmarkets.com/research/cng4gn/refurbished ) has ... Market - Global Forecasts to 2019" report to ... market is estimated to grow expected to reach $9.37 ... 2014 to 2019. Factors such ... financial constraints, increasing privatization in the healthcare sector, and ...
Breaking Medicine Technology:Amgen Announces 2015 Third Quarter Dividend 2Amgen Announces 2015 Third Quarter Dividend 3Cumberland Pharmaceuticals To Announce Second Quarter 2015 Financial Results 2Refurbished Medical Equipment Market 2015 - Global Forecasts to 2019 2
... forward Juwan Howard and Basketball Hall of Famer Bob Lanier ... Health and Medicine (SAHM) today to bring Vaccines for ... is a national awareness campaign designed to educate teens ... and potentially life-threatening diseases. To tip off ...
... NEW YORK, Feb. 9, 2011 Reportlinker.com ... is available in its catalogue: ... Pharmaceutical applications by geography, technology trends and ... Report Description ...
Cached Medicine Technology:Miami HEAT Forward Juwan Howard and NBA Legend Bob Lanier Join Vaccines for Teens Educational Campaign to Urge Local Teens to Take Their Best Shot at Health 2Miami HEAT Forward Juwan Howard and NBA Legend Bob Lanier Join Vaccines for Teens Educational Campaign to Urge Local Teens to Take Their Best Shot at Health 3Miami HEAT Forward Juwan Howard and NBA Legend Bob Lanier Join Vaccines for Teens Educational Campaign to Urge Local Teens to Take Their Best Shot at Health 4Miami HEAT Forward Juwan Howard and NBA Legend Bob Lanier Join Vaccines for Teens Educational Campaign to Urge Local Teens to Take Their Best Shot at Health 5Reportlinker Adds Global Anti-counterfeit Markets in Food & Pharmaceutical Applications by Geography, Technology Trends and Forecasts (2010-2015) 2Reportlinker Adds Global Anti-counterfeit Markets in Food & Pharmaceutical Applications by Geography, Technology Trends and Forecasts (2010-2015) 3Reportlinker Adds Global Anti-counterfeit Markets in Food & Pharmaceutical Applications by Geography, Technology Trends and Forecasts (2010-2015) 4
(Date:7/28/2015)... ... 2015 , ... The Triumph Modular, Redefining Modular™ site offers ... library, floor plans, educational blog and wide use of imagery. The Design Build ... valuable links to useful reports by industry experts. Comments are welcomed and encouraged. ...
(Date:7/28/2015)... ... July 28, 2015 , ... A ... outcomes for inmates who continued methadone maintenance treatment (MMT) during incarceration versus those ... to relapse to opiate use (1) and more likely to require hospitalization or ...
(Date:7/28/2015)... ... 2015 , ... The Denver Foundation and Blair-Caldwell African American ... a photographic and narrative exploration of African American giving, which runs August 1-31 ... Denver is one of only ten cities to host “The Soul of Philanthropy ...
(Date:7/28/2015)... ... 28, 2015 , ... Dr. Edward Buckingham and Buckingham Center for ... July 2016. Coming to Austin from Philadelphia, Dr. Roy will be completing his ... training is facilitated annually by the American Academy of Facial Plastic and Reconstructive Surgery. ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... Obama’s visit to Ethiopia to learn more about the impact of U.S. collaborations ... This initiative focuses on accelerating agricultural development as an engine of broad-based economic ...
Breaking Medicine News(10 mins):Health News:Triumph Modular Launches Refreshed Modular Building Industry Website 2Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 2Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 3Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 4Health News:"The Soul of Philanthropy Reframed and Exhibited” Comes to Denver 2Health News:Buckingham Center for Facial Plastic Surgery Welcomes Fellow 2Health News:Buckingham Center for Facial Plastic Surgery Welcomes Fellow 3Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 2Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 3Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 4
... is now possible to repair the damages in the heart from ... stem cells from mice to repair heart damage in sheep, reporting ... The Lancet. ,Heart failure is a major cause of death ... after a heart attack. Before now, embryonic stem cells had been ...
... in the field of cancer and our improved understanding of ... strategy to treat the disease is not so far // ... large family known as the metalloproteinases – many of which ... tumor metastasis, or spread, through the body. Earlier studies have ...
... possible using anti-nicotine vaccine. ,Are you a chain smoker ... vaccine could help., ,Swiss scientists have developed a ... the smoker // with no kick, reports news portal ... by Swiss pharmaceutical firm Cytos, works by building antibodies ...
... Research presented in the Journal of Epidemiology and Community Health ... and increases their chances // of being depressive much more., ... men and women taking part in the Newcastle Thousand Families ... 1947 to mothers living in Newcastle upon Tyne, north east ...
... fastest progressing and spreading diseases of present time’s arthritis is ... direction and a new study states that pomegranate fruit extracts ... ,The study was conducted at Case Western Reserve University ... extract of pomegranate fruit against Interleukin-1b (IL-1b), a pro-inflammatory protein ...
... to dominate women may be at the heart of ... - explains half the discrepancy in life expectancy between ... in the Journal of Epidemiology and Community Health. The ... rates of female murders and male death rates from ...
Cached Medicine News:Health News:Breast Cancer Advance 2Health News:Pomegranate Juice Is Helpful In Arresting Osteoarthritis 2
ECG pocket is a handy reference for identifying common ECG findings....
... Cochrane Reviews enable all those involved with ... with the very latest evidence in their ... becomes harder each year as the volume ... problem by delivering the best single source ...
... Anatomy Flash Cards is ... the heart, veins, and ... system. It uses the ... images from BryanEdwards.com and ...
This is designed to synthesize current cardiovascular research findings for busy physicians and healthcare professionals....
Medicine Products: